Clinical Trial Update: Clinical Study of GH001 in Depression [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical study of GH001 for treatment-resistant depression and major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• GH001

Snippet

Sponsor: GH Research Ireland Limited | Conditions: Treatment Resistant Depression, Major Depressive Disorder | Phase 1, Phase 2 | Status: COMPLETED